Prospective Prostate Cancer and Patient-reported Outcomes Registry
Recruiting · NCT04694924 · Observational (researchers observe without assigning treatment) · Lead sponsor: Universitaire Ziekenhuizen KU Leuven
View the official record on ClinicalTrials.gov →Interventions studied
standard of care
What this trial is about
This study aims to evaluate the use of a digital solution, integrated into the electronic health record, for prospective and structured reporting of clinical and patient-reported outcomes for patients diagnosed with localized or locally advanced prostate cancer.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Pathology confirmed diagnosis of localized or locally advanced prostate cancer
- Being able to speak, read and understand Dutch, French, or English
- Each patient (or their legally acceptable representative) must sign an informed consent form (ICF) indicating that he understands the purpose of, and is willing to participate in the study.
Exclusion criteria
- Patients with prior treatment for prostate malignancies will be excluded.
- Dementia, mental alteration, or psychiatric pathology that can compromise informed consent from the patient and/ or adherence to the protocol and the monitoring of the trial
- Patients who cannot submit themselves to following the protocol for psychological reasons, social, family, or geographical.
- Persons deprived of liberty or under guardianship
Where it is running
4 locations listed.
- AZ Sint-Blasius - Dendermonde, Oost-Vlaanderen, Belgium
- University Hospitals Leuven - Leuven, Vlaams-Brabant, Belgium
- AZ Sint-Jan Brugge - Bruges, West-Vlaanderen, Belgium
- AZ Groeninge Kortrijk - Kortrijk, West-Vlaanderen, Belgium